Great points from the Jacobean afficionado! After all, Culloden stands as testament to the fact that some people would rather die than think. The witty repartee from my favourite pedant, and his acolyytes has ensured that I will remain on the sidelines in any discussion on MSB in the near future. Suffice it to say, I acknowledge the risks attaching to investment in this stock and accept them. I have no desire to convince anyone else of the merits or otherwise of investment here as everyone has different investment objectives and investment in the bio-tech sector is certainly not for the faint-hearted. I have a giggle when reading the thoughts of the rich and famous on the investment merits of CSL as I remember when the Govt floated them in the early 1990's at around $2.50 ps. I know that it was a difficult sell for the broker/s involved at that time, as not too many saw a great future for the company. Patently, CSL has been a great success, and whilst I recognise that the success/failure ratio is heavily slanted towards failure in this sector, I fancy MSB's chances.
- Forums
- ASX - By Stock
- Share Price Increase to $10.93
Great points from the Jacobean afficionado! After all, Culloden...
-
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.46 | 27045 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | 1.450 |
2 | 5794 | 1.445 |
6 | 50901 | 1.440 |
4 | 52442 | 1.435 |
5 | 177906 | 1.430 |
Price($) | Vol. | No. |
---|---|---|
1.455 | 27045 | 2 |
1.460 | 64331 | 5 |
1.465 | 35901 | 2 |
1.470 | 54504 | 2 |
1.480 | 132521 | 3 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
LGP
Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
MSB (ASX) Chart |